Last reviewed · How we verify
salmeterol and fluticasone propionate — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
salmeterol and fluticasone propionate (salmeterol and fluticasone propionate) — Arthur F Gelb MD.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| salmeterol and fluticasone propionate TARGET | salmeterol and fluticasone propionate | Arthur F Gelb MD | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- salmeterol and fluticasone propionate CI watch — RSS
- salmeterol and fluticasone propionate CI watch — Atom
- salmeterol and fluticasone propionate CI watch — JSON
- salmeterol and fluticasone propionate alone — RSS
Cite this brief
Drug Landscape (2026). salmeterol and fluticasone propionate — Competitive Intelligence Brief. https://druglandscape.com/ci/salmeterol-and-fluticasone-propionate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab